1.Chairman Wang Shanpu of Modern Biological Group made an annual summary and planned a new blueprint for development. In 2025, the deepened its focus on the life and health industry, worked hard to overcome difficulties, innovated and developed, solidified the foundation of research and development, and achieved a dual increase brand influence and team collaboration efficiency, successfully completing various business tasks. In 2026, the Group will take technological innovation as the core, unite as one, strive for, and work together to create a new situation of high-quality development.

According to the provisions of the Regulations on the Administration of Veterinary Drugs and the Measures for the Administration of Approval Numbers of Veterinary Drug Products, examination by the Ministry of Agriculture and Rural Affairs, the production of duck infectious bacteremia and colibacillosis bivalent inactivated vaccine (CZ12 strain 1 O78 strain SH) by Luoyang Worpson Biological Engineering Co., Ltd. is approved, and the approval number of veterinary drug products is.

1.Recently, the Ministry of Agriculture and Rural Affairs issued Announcement No. 981, according to the provisions of the "Regulations on Administration of Veterinary Drugs" and the "Measures for the Registration of Veterinary Drugs", after strict examination, it was approved that the "Porcine Reproductive andpiratory Syndrome Virus NSP7 Fluorescent Microsphere Antibody Test Strip" declared by Luoyang Laipson Information Technology Co., Ltd. and Luang Modern Biotechnology Research Institute Co., Ltd. was approved as a new veterinary drug.

1.In early winter, The overseas Russia and Senegal clients visited Laipson ear tag exhibition hall, ear tag production workshop, and had a friendly negotiation last. Laipson’s ear tags have good quality and service. So the clients are willing to cooperate with Laipson all the time. Mutual trust&support bring closer and longer cooperation regarding ear tags!

Modern Biogen Group has been deeply involved in the field of biotechnology for many years, focusing on the full industrial chain of animal health. Through the major business segments of animal identification and traceability system, veterinary testing and diagnostic reagents, therapeutic antibodies and preventive vaccines, it has built a complete industrial ecology for animal health. The this time is a comprehensive affirmation of its comprehensive strength in terms of core intellectual property rights, R&D and transformation capabilities, and organizational management level.

Both parties are committed to the global trend of vaccine industry upgrading and core needs, and take the "full-link precision traceability technology system" built by group in the field of animal traceability and the "formulation research and development and industrialization technology matrix" formed by the vaccine sector as strategic support points, carry out multi- cooperation, and jointly outline the high-level blueprint of future international cooperation projects.